Prescription Trends of Biologic DMARDs in Treating Rheumatologic Diseases: Changes of Medication Availability in COVID-19

Biologic disease-modifying antirheumatic drugs (DMARDs) are very effective in treating rheumatic diseases with a good patient tolerance. However, high cost and individualistic approach requires dedication of the physician. Therefore, the aim of this study was to determine how the COVID-19 pandemic h...

Descripción completa

Detalles Bibliográficos
Autores principales: Radić, Mislav, Đogaš, Hana, Vrkić, Karla, Gelemanović, Andrea, Marinović, Ivanka, Perković, Dijana, Nazlić, Jurica, Radić, Josipa, Krstulović, Daniela Marasović, Meštrović, Julije
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10455961/
https://www.ncbi.nlm.nih.gov/pubmed/37623450
http://dx.doi.org/10.3390/jpm13081199

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10455961/
https://www.ncbi.nlm.nih.gov/pubmed/37623450
http://dx.doi.org/10.3390/jpm13081199

Ejemplares similares